Stryker price target lowered to $310 from $340 at Truist
Downgrade suggests headwinds; upside potential remains but tempered.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Downgrade suggests headwinds; upside potential remains but tempered.
What happened, with direct paths to the underlying reporting
Truist lowered Stryker's target to $310 from $340. The current price is about $280.23, leaving some upside potential but with a reduced target.
Target: $310
Posted price: $280.23
Analyst firm: Truist Financial
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.